{
  "id": 521,
  "text": "# SYSTEMIC THERAPYFOR CERVICALCANCERa <html><body><table><tr><td colspan=\"3\">Small Cell NECC!</td></tr><tr><td rowspan=\"2\">Chemoradiationm</td><td colspan=\"2\">Recurrent or Metastatic Disease</td></tr><tr><td>First-line Therapyf Preferred Regimens</td><td>Second-line or Subsequent Therapy Other Recommended Regimens</td></tr><tr><td>Preferred Regimens Other Recommended Regimens · Carboplatin + etoposide if patient is cisplatin intolerant' ·Cisplatin + etoposidel222</td><td>· Cisplatin/etoposide · Carboplatin/etoposide Other Recommended Regimens ·Cisplatin/etoposide+atezolizumab</td><td>·Bevacizumab9 · Albumin-bound paclitaxel · Docetaxel · Topotecan ·Topotecan/paclitaxel</td></tr></table></body></html> # 指南重点内容 !",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: # SYSTEMIC THERAPYFOR CERVICALCANCERa <html><body><table><tr><td colspan=\"3\">Small Cell NECC!</td></tr><tr><td rowspan=\"2\">Chemoradiationm</td><td colspan=\"2\">Recurrent or Metastatic Disease</td></tr><tr><td>First-line Therapyf Preferred Regimens</td><td>Second-line or Subsequent Therapy Other Recommended Regimens</td></tr><tr><td>Preferred Regimens Other Recommended Regimens · Carboplatin + etopo\n\n<question>: \n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n",
  "ChatGPT_response_0": "对于宫颈癌系统治疗中首次治疗复发或转移性疾病的首选方案，常用的是含有铂类药物的化疗方案，如卡铂联合依托泊苷或者顺铂联合依托泊苷。这些方案适用于对顺铂耐受的患者。此外，免疫治疗可以作为传统化疗的补充，以提高治疗效果。",
  "query": "宫颈癌的系统疗法中，首次治疗复发或转移性疾病的首选方案是什么？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 宫颈癌的系统疗法中，首次治疗复发或转移性疾病的首选方案是什么？\n\n<reference text>: # SYSTEMIC THERAPYFOR CERVICALCANCERa <html><body><table><tr><td colspan=\"3\">Small Cell NECC!</td></tr><tr><td rowspan=\"2\">Chemoradiationm</td><td colspan=\"2\">Recurrent or Metastatic Disease</td></tr><tr><td>First-line Therapyf Preferred Regimens</td><td>Second-line or Subsequent Therapy Other Recommended Regimens</td></tr><tr><td>Preferred Regimens Other Recommended Regimens · Carboplatin + etoposide if patient is cisplatin intolerant' ·Cisplatin + etoposidel222</td><td>· Cisplatin/etoposide · Carboplatin/etoposide Other Recommended Regimens ·Cisplatin/etoposide+atezolizumab</td><td>·Bevacizu\n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n\n<reply>: ",
  "response": "对于宫颈癌系统治疗中首次治疗复发或转移性疾病的首选方案，常用的是含有铂类药物的化疗方案，如卡铂联合依托泊苷或者顺铂联合依托泊苷。这些方案适用于对顺铂耐受的患者。此外，免疫治疗可以作为传统化疗的补充，以提高治疗效果。"
}